Education background
- April 2007: Degree in Pharmaceutical Biotechnology, with honors, at the University “La Sapienza”, Rome, Italy
April 2013: PhD in Immunology and Applied Biotechnologies at the University “Tor Vergata”, Rome,
Work experience/Current and previous research interests;
The expertise of AM is mainly focused on isolation by phage display, characterization and engineering of recombinant antibodies for innovative therapeutic strategies.
Through time, this expertise was applied in a broad range research projects aimed to implement antibodies or antibody-based constructs, specific for viral, tumoral and, more recently, immunocheckpoints antigens.
AM participated to the development of a new human scFv-phage library
Education background
- April 2007: Degree in Pharmaceutical Biotechnology, with honors, at the University “La Sapienza”, Rome, Italy
April 2013: PhD in Immunology and Applied Biotechnologies at the University “Tor Vergata”, Rome,
Work experience/Current and previous research interests;
The expertise of AM is mainly focused on isolation by phage display, characterization and engineering of recombinant antibodies for innovative therapeutic strategies.
Through time, this expertise was applied in a broad range research projects aimed to implement antibodies or antibody-based constructs, specific for viral, tumoral and, more recently, immunocheckpoints antigens.
AM participated to the development of a new human scFv-phage library